Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis

BACKGROUND: India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India’s pharmaceutical industry is the third largest, by volume, globally, but access to CVD drugs i...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, Charles, Ajay, Vamadevan S., Srinivas, Ravi, Bhalla, Sandeep, Prabhakaran, Dorairaj, Banerjee, Amitava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852445/
https://www.ncbi.nlm.nih.gov/pubmed/27141309
http://dx.doi.org/10.1186/s40545-016-0065-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852445/
https://www.ncbi.nlm.nih.gov/pubmed/27141309
http://dx.doi.org/10.1186/s40545-016-0065-7

Ejemplares similares